Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Post by eSnowdenon Aug 13, 2019 10:03pm

158 Views

Post# 30025386

ReDS $50k in quarterly sales??

Looks like Friessen got caught up in another Prexxartan scam. A $10million investment for a 7% stake in Sensible medical. Thats over a $100million co. valuation for a 1 product company that brought in a whopping $150k in sales over a 6 month period. Geez, Medicure brings in nearly $25million in sales and has a valuation nearly half of that. Doesn't seem very sensible to me.

Bullboard Posts

Stockhouse DealRoom opens new Australian opportunities